Doxorubicin (AlphaRx)

N/A

Report date: 2026/01/26 13:50:17

Base Information

Drug NameDoxorubicin (AlphaRx)
Drug Alias Namedoxorubicin
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > Anthracycline antibiotics
Mechanisms of ActionTopoisomerase II inhibitorsVirus DNA polymerase inhibitorsDNA intercalators
TargetsVirus DNA polymeraseDNATopoisomerase II
Therapy Area/IndicationsCarcinoma, Hepatocellular
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUmeworld
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUmeworld
Active IndicationsN/A
Inactive IndicationsCarcinoma, Hepatocellular

Other Information

ATC CodeN/A
Related LinksN/A